These observations raised the possibility that pre-treatment of cardiac stem cells with any of these molecules could render them more effective regenerating diseased cardiac tissue. To test this hypothesis Martins, Clavo and colleagues used fluorescence-marked human cardiac stem cells treated with ATP or histamine. These cells were injected into mice with suppressed immune systems (so that the injected human cells are not rejected) after a heart injury, and the results compared with those obtained from injections with non-treated cardiac stem cells (controls). The researchers found that, 48 hours after injection, pre-treated cells were surviving in higher numbers and dividing much more (10 time more) than non-treated cells. Even more interesting, by this time they start showing markers characteristic of cardiomyocytes and expressing molecules known to participate in cell-to-cell adhesion suggesting that pre-treated cells are differentiating into cardiomyocytes and regenerating the injured heart. And in fact, after 7 days, mice injected with pre-treated cells not only had three times more cardiomyocytes than control animals, but their heart function was also much better supporting the idea that heart regeneration had, in fact, occur.
These results suggest that cardiac stem cells, if induced to increase their internal calcium oscillations, can be activated to regenerate dead heart tissue after a heart attack stopping function loss and, as result, also the danger of future heart failure.
If Martins, Clavo and colleagues' results can be transferred to patients they may pave the way to a completely different, and more effective, approach to the treatment of cardiovascular diseases, something particularly important in the times we live in. In fact, despite several advances in cardiovascular care 17 million people still die every year of a disease that seems irrevocably linked to the lifestyle of stress, bad diet and lack of exercise typical of developed societies. As such, and at least for now, disease numbers are predicted to keep increasing worldwide. A good example are the United States where it remains the number one killer, being responsible for almost a third of all deaths in the country, and where one million of people suffers a heart attack every year, with the American Heart Association predicting that in 2009 half a million Americans will experience their first heart attack and that, from these, 18 to 36% will suffer a second episode in 6 years.
circres.ahajournals/cgi/content/full/105/8/764